glp 1 agonist heart disease Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Heart transplantation in the GLP-1
Description
& Herman, L
Are GLP-1 Medications Worth the Cost
There are some serious trade-offs, though: Liraglutide is administered subcutaneously, and it causes nausea in about two-thirds of patients
Ultra-processed foodscharacterized by high energy density, industrially engineered palatability and textures that facilitate rapid consumptionhave been shown, in a meta-analysis of 43 observational studies, to significantly increase the risk of general obesity (OR 1.51
Protein, protein, protein
